Emergency Intervention Thresholds for Hyperglycemia

Immediate Emergency Department Presentation Required

The American Diabetes Association recommends immediate emergency care for blood glucose ≥180 mg/dL accompanied by vomiting, dehydration, or altered mental status to prevent life-threatening complications including diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) 2, 1
The American College of Clinical Endocrinologists suggests emergency department evaluation for blood glucose ≥250 mg/dL persistently over 2 consecutive days, even in the absence of symptoms 1
Any glucose reading exceeding the home glucometer's measurement capacity (typically >600 mg/dL) requires immediate emergency presentation, as recommended by the American Association of Clinical Endocrinologists 1
Signs of DKA, including plasma glucose ≥250 mg/dL with arterial pH <7.30, bicarbonate <15 mEq/L, and presence of ketones, represent a life-threatening emergency requiring immediate medical intervention, according to the American Diabetes Association 3, 4, 1
Signs of HHS, including blood glucose ≥600 mg/dL with effective serum osmolality ≥320 mOsm/kg, impaired mental status, or altered consciousness, are a medical emergency, as stated by the American College of Clinical Endocrinologists 4, 1

For non-ICU patients, the American Diabetes Association recommends initiating insulin therapy for persistent hyperglycemia ≥180 mg/dL confirmed on two occasions within 24 hours, with a target glycemic goal of 140-180 mg/dL 5, 6, 7
For ICU patients, the Society of Critical Care Medicine suggests maintaining blood glucose between 140-180 mg/dL for most critically ill individuals, with more stringent goals of 110-140 mg/dL for selected patients, if achievable without significant hypoglycemia 5, 6, 7
The NICE-SUGAR trial demonstrated that overly aggressive glycemic control (targeting 80-110 mg/dL) resulted in 10- to 15-fold higher rates of hypoglycemia and increased mortality compared to moderate targets, fundamentally changing practice guidelines, as reported by the American College of Physicians 5, 6, 7

Pregnant patients with any concern for DKA require immediate medical attention due to significant feto-maternal harm risk, as recommended by the American College of Obstetricians and Gynecologists 1
Patients on SGLT2 inhibitors with glucose >200 mg/dL and ketones present warrant immediate evaluation, as euglycemic DKA can occur even with glucose <250 mg/dL, according to the American Diabetes Association 1
Youth with Type 2 Diabetes and blood glucose ≥250 mg/dL with symptoms require immediate evaluation, as stated by the American Academy of Pediatrics 1
Type 1 diabetes patients require more frequent monitoring (every 4-6 hours) during intercurrent illness, as the stress of illness frequently aggravates glycemic control and increases DKA risk, according to the American Diabetes Association 3

Home management is only appropriate for patients with glucose >200 mg/dL and mild symptoms who are hemodynamically stable, cognitively intact, able to tolerate oral hydration, can administer subcutaneous insulin, perform frequent blood glucose and ketone monitoring, and have access to diabetes care team support, as recommended by the American Association of Diabetes Educators 1
Nausea or vomiting accompanied by hyperglycemia should prompt immediate medical evaluation rather than home management, as this may indicate DKA, according to the American College of Gastroenterology 3

Correctional and institutional facilities should implement policies requiring physician notification for blood glucose <50 mg/dL or >350 mg/dL, as recommended by the National Commission on Correctional Health Care 1
Systems must be in place to identify patients with consistently elevated blood glucose and intercurrent illness, according to the American Medical Association 3

Do not dismiss glucose >200 mg/dL in symptomatic patients, even with chronic poor control, as this may represent acute decompensation requiring emergency intervention, as warned by the American Diabetes Association 1
Do not wait for classic DKA symptoms in pregnant patients, as presentation may be atypical, according to the American College of Obstetricians and Gynecologists 1
Do not assume safety from DKA in SGLT2 inhibitor users if glucose is <250 mg/dL, as euglycemic DKA can occur, as cautioned by the American Diabetes Association 1
Do not confuse altered mental status from hyperglycemia with intoxication or withdrawal—immediately check blood glucose in any patient with diabetes exhibiting confusion, agitation, or diaphoresis, as recommended by the American College of Emergency Physicians 3